Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.

Diagnostic cytopathology - 1 Dec 2022

Rekhi Bharat, Dodd Leslie, Dharavath Bhaskar, Dutt Amit

Abstract excerpt

Spindle cell/sclerosing rhabdomyosarcoma (RMS), characterized by MYOD1 (L122R) mutation in a subset of cases is a newly described subtype of RMS. Presently, there is no documentation of cytomorphological features, especially of sclerosing RMS. Case 1: A 24-year-old male presented with pain and swelling in his wrist for a one-year duration. MRI revealed a well-defined soft tissue lesion measuring 5.3 cm, encasing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Child
Share to Desmin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MyoD Protein

Share to Myogenin

Share to Rhabdomyosarcoma

Share to Rhabdomyosarcoma, Embryonal

Share to Young Adult

Source

Identifiers

PMID: 35929754
DOI: 10.1002/dc.25032

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.PMID 35929754Read ↗

The expanding morphological and genetic spectrum of MYOD1 ‐mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non‐mutated casesSemantic proximity Read ↗

MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.Semantic proximity Read ↗

MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.Semantic proximity Read ↗

Spindle Cell/Sclerosing Rhabdomyosarcoma of the Orbit.Semantic proximity Read ↗

Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.Semantic proximity Read ↗

Challenges in the Diagnosis of Pediatric Spindle Cell/Sclerosing Rhabdomyosarcoma.Semantic proximity Read ↗

The current landscape of rhabdomyosarcomas: an update.Semantic proximity Read ↗

[Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].Semantic proximity Read ↗

Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity: MYOD1-mutation and Clonal Evolution.Semantic proximity Read ↗

Molecular profile of head and neck rhabdomyosarcomas: A systematic review and meta-analysis.Semantic proximity Read ↗

Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.Semantic proximity Read ↗

Clinicopathological features of five unusual cases of intraosseous myoepithelial carcinomas, mimicking conventional primary bone tumours, including EWSR1 rearrangement in one case.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.